Imugene raises $11.1 million to advance azer-cel after complete responses in early cohort

Imugene (ASX: IMU) plans a two-tranche placement to raise about A$11.12 million before costs, aiming to strengthen its balance sheet. The recapitalization is modestly supportive for financial resilience, though it is primarily a funding update rather than an earnings or guidance change.

Analysis

Imugene (ASX: IMU) plans a two-tranche placement to raise about A$11.12 million before costs, aiming to strengthen its balance sheet. The recapitalization is modestly supportive for financial resilience, though it is primarily a funding update rather than an earnings or guidance change.